Bariatrics Amgen 133: Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Participants With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus Obesity Overweight
Cardiovascular Cardiovascular Clinical Trial - Ablative Solutions - Ablative Solution - CR0002 The TARGET - Ablative Solutions CR0002 The Target BP I